scholarly article | Q13442814 |
P819 | ADS bibcode | 2008PNAS..10510119E |
P356 | DOI | 10.1073/PNAS.0802753105 |
P932 | PMC publication ID | 2481335 |
P698 | PubMed publication ID | 18626012 |
P5875 | ResearchGate publication ID | 5226388 |
P50 | author | Salem Chouaib | Q98108267 |
Fathia Mami-Chouaib | Q100288215 | ||
P2093 | author name string | Vladimir Lazar | |
Vincent Stroobant | |||
Jean-François Baurain | |||
Pierre G Coulie | |||
Isabelle Vergnon | |||
Faten El Hage | |||
Hamid Echchakir | |||
P2860 | cites work | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin | Q24532827 |
Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets | Q24534284 | ||
Adoptive immunotherapy for cancer: building on success | Q24546258 | ||
Cancer immunotherapy: moving beyond current vaccines | Q24548229 | ||
Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis | Q24679720 | ||
Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E | Q28181479 | ||
A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma | Q28189622 | ||
Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis | Q28203510 | ||
Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes | Q28206209 | ||
Identification of signal peptide peptidase, a presenilin-type aspartic protease | Q28206228 | ||
Signal peptide peptidase forms a homodimer that is labeled by an active site-directed gamma-secretase inhibitor | Q28236978 | ||
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C | Q28263511 | ||
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products | Q28264638 | ||
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing | Q28266416 | ||
Isolation and characterization of human calcitonin gene-related peptide | Q28645701 | ||
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation | Q30434689 | ||
Degradation of cell proteins and the generation of MHC class I-presented peptides | Q33652524 | ||
The translocon: a dynamic gateway at the ER membrane | Q33804360 | ||
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells | Q33888972 | ||
Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution. | Q34035248 | ||
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides | Q34372218 | ||
Proteolysis, proteasomes and antigen presentation | Q35228583 | ||
The chemistry and enzymology of the type I signal peptidases | Q36280398 | ||
Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein | Q36365365 | ||
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens | Q36402611 | ||
A physiological role for calcitonin: protection of the maternal skeleton | Q39568647 | ||
Calcitonin: physiology and pathophysiology | Q40295376 | ||
A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma | Q40351656 | ||
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival | Q40809629 | ||
Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung. | Q40890155 | ||
The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. | Q40993314 | ||
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen | Q41870799 | ||
Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo | Q43001715 | ||
Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge | Q45779304 | ||
The complete sequence of human preprocalcitonin | Q48392537 | ||
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. | Q53438021 | ||
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. | Q54528048 | ||
Signal sequences: more than just greasy peptides | Q56639128 | ||
3,4-Dichloroisocoumarin, a serine protease inhibitor, inactivates glycogen phosphorylase b | Q58023511 | ||
Letter: Hypersecretion of calcitonin in neoplastic conditions | Q70010774 | ||
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours | Q70019756 | ||
Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen | Q71655418 | ||
Expression of mage genes by non-small-cell lung carcinomas | Q72272098 | ||
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer | Q72682038 | ||
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes | Q72992805 | ||
Non-traditionally derived CTL epitopes: exceptions that prove the rules? | Q77723677 | ||
Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination | Q78536727 | ||
P433 | issue | 29 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytotoxicity | Q246181 |
P304 | page(s) | 10119-10124 | |
P577 | publication date | 2008-07-14 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway | |
P478 | volume | 105 |
Q27023313 | A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens |
Q24306596 | A protease-independent function for SPPL3 in NFAT activation |
Q26864074 | Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome |
Q28547947 | Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase Inhibitors |
Q89965263 | Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children |
Q37851046 | Generation of MHC class I ligands in the secretory and vesicular pathways |
Q41533232 | Human Tumor Antigens and Cancer Immunotherapy |
Q44315577 | Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients. |
Q59799214 | Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours |
Q99636466 | IFN-γ treatment protocol for MHC-Ilo/PD-L1+ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential |
Q64997870 | Identification of non-mutated neoantigens presented by TAP-deficient tumors. |
Q47101668 | Insights into the mechanism of isoenzyme-specific signal peptide peptidase-mediated translocation of heme oxygenase |
Q37851050 | Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes |
Q34512655 | NK Cell Maturation and Cytotoxicity Are Controlled by the Intramembrane Aspartyl Protease SPPL3. |
Q46383217 | Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires |
Q60957167 | Preproinsulin Designer Antigens Excluded from Endoplasmic Reticulum Suppressed Diabetes Development in NOD Mice by DNA Vaccination |
Q38269935 | Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex |
Q92106808 | Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing |
Q49432766 | Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy. |
Q37844333 | Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development |
Q38984568 | Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity |
Q43290433 | Signal peptide peptidases are expressed in the shoot apex of rice, localized to the endoplasmic reticulum |
Q37476307 | Signal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 transmembrane proteins. |
Q38262570 | Signal peptides: new markers in cardiovascular disease? |
Q38072774 | TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes |
Q92628359 | TEIPP peptides: exploration of unTAPped cancer antigens |
Q38984559 | Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression. |
Q39593426 | The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. |
Q38818906 | The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis |
Q39171951 | The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes |
Q34315858 | mRNA surveillance and endoplasmic reticulum quality control processes alter biogenesis of mutant GABAA receptor subunits associated with genetic epilepsies |
Search more.